![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
Injective (INJ) has enjoyed a recent rally, trading at $26.29 at press time. This marks a 33% price increase over the past week. However, futures traders have placed short bets against INJ, setting the stage for a potential short squeeze as the token price continues to rise.
This development comes as Injective is set to transition from version 2.0 to 3.0, following a governance proposal that passed with 99.99% approval. This upgrade will reduce the supply of INJ tokens, making it “one of the most deflationary assets over time.”
The hype surrounding this upgrade is largely contributing to the INJ price rally, with a 18% price increase over the past two days. Notably, despite this rally, INJ futures traders appear unimpressed and have maintained a demand for short positions.
This trend is evident in INJ's Long/Short Ratio, which stands at 0.99 at press time. This ratio compares the number of long positions (bets that the price will rise) to short positions (bets that the price will fall) in a market. When the ratio is below 1, it indicates that there are more short positions than long positions, suggesting a bearish sentiment among traders.
However, with increasing demand for INJ, these traders might face a potential short squeeze. A short squeeze occurs when a shorted asset experiences a price increase, compelling short sellers to buy back their positions to minimize losses. This buying pressure can drive the price even higher, creating a feedback loop that accelerates the upward trend.
INJ's rising Relative Strength Index (RSI) is also worth considering. At press time, this momentum indicator is in an uptrend at 58.88.
The RSI indicator measures an asset’s oversold and overbought market conditions. It ranges between 0 and 100, with values above 70 indicating that the asset is overbought and due for a correction. On the other hand, values under 30 indicate that the asset is oversold and may witness a rebound.
At 58.88, INJ's RSI indicates that the asset is in a neutral to slightly bullish zone. The price momentum shows more buying than selling pressure but is not yet overbought.
Moreover, readings from INJ's Moving Average Convergence Divergence (MACD) indicator support this bullish outlook. At press time, the token's MACD line (blue) is positioned above its signal line (orange).
When this indicator is set up this way, it indicates bullish momentum. This means that if the trend persists, the Injective token price may continue to rise.
INJ Price Prediction: Can Momentum Push the Price Above $30?
As buying pressure builds up, INJ's price could breach the resistance encountered at $28.72. If the bulls can sustain this momentum, INJ could rally back above $30 and approach its multi-month high of $35.26.
On the other hand, if the short bets prevail and the Injective token price reverses its current trend, it could plummet to $24.44.
免责声明:info@kdj.com
所提供的信息并非交易建议。根据本文提供的信息进行的任何投资,kdj.com不承担任何责任。加密货币具有高波动性,强烈建议您深入研究后,谨慎投资!
如您认为本网站上使用的内容侵犯了您的版权,请立即联系我们(info@kdj.com),我们将及时删除。
-
- REMITTIX(RTX)价格预测:它会在Shib的脚步中遵循吗?
- 2025-04-26 15:55:13
- 在加密世界中引起新鲜海浪的举动,银行巨头标准已将其支撑在XRP价格后面
-
-
- 您现在对$ wld有多乐观?
- 2025-04-26 15:50:13
- 让我们快速玩游戏。 🎮
-
-
-
-
- 以太坊(ETH)随着价格目标$ 1850的价格激增了关键阻力
- 2025-04-26 15:40:16
- ETH/BTC交易对保持接近0.01835的职位,这是其在多年历史上最低点之一。
-
- 与传统金融相比,比特币(BTC)最近见证了明显的转变
- 2025-04-26 15:40:16
- 根据OKX Ventures的数据,比特币已正式与美国的股票市场脱钩,同时加强了其与贵金属黄金的相关性。
-
- 贝莱德XRP ETF批准时间表仍然不确定
- 2025-04-26 15:35:13
- XRP ETF批准时间表仍然不确定,因为贝莱德和其他主要资产经理都在等待完全的监管清晰度。